Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Chemotherapy-induced Neutropenia × balugrastim × Clear all

Phase

Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Chemotherapy-induced Neutropenia 2 Solid Tumors 1

Interventions

pegfilgrastim 7 NPI 2358 4 Granulocyte Colony-Stimulating Factor 3 Doxorubicin 3 Docetaxel 3 balugrastim 2 Drug Therapy 2 Cyclophosphamide 2 pegylated granulocyte colony-stimulating factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00837265 2024-04-03

NEUGR-002

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2/3 Completed

334 enrolled 16 charts

Chemotherapy-induced Neutropenia

NCT01126190 2023-03-28

NEUGR-003

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 3 Completed

381 enrolled 13 charts

Chemotherapy-induced Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡